Current Issue - March 2022, Volume 16, Issue No. 1

1. Murray DJ, Javed S, Jain N, Kemp S, Watts AC. Platelet-Rich-Plasma Injections in Treating Lateral Epicondylosis: a Review of the Recent Evidence. J Hand Microsurg. 2015; 7(2): 320-5. doi: 10.1007/s12593-015-0193-3
2. McMurtrie A, Watts AC. Tennis elbow and golfers elbow: a review article. Orthop Trauma. 2012; 26(5): 297-366. doi: 10.1016/j.mporth.2012.09.001
3. Szabo SJ, Savoie FH 3rd, Field LD, Ramsey JR, Hosemann CD. Tendinosis of the extensor carpi radialis brevis: an evaluation of three methods of operative treatment. J Shoulder Elbow Surg. 2006; 15(6): 721-7. doi: 10.1016/j.jse.2006.01.017
4. Edwards SG, Calandruccio JH. Autologous blood injections for refractory lateral epicondylitis. J Hand Surg Am. 2003; 28(2): 272-8. doi: 10.1053/jhsu.2003.50041
5. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006; 34(11): 1774-8. doi: 10.1177/0363546506288850
6. Sun Y, Feng Y, Zhang CQ, Chen SB, Cheng XG. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop. 2010; 34(4): 589-97. doi: 10.1007/s00264-009-0793-2
7. Coombes BK, Bisset L, Vicenzino B. A new integrative model of lateral epicondylalgia. Br J Sports Med. 2009; 43(4): 252-8. doi: 10.1136/bjsm.2008.052738
8. Finnoff JT, Fowler SP, Lai JK, Santrach PJ, Willis EA, Sayeed YA, et al. Treatment of chronic tendinopathy with ultrasound- guided needle tenotomy and platelet-rich plasma injection. PM R. 2011; 3(10): 900-11. doi: 10.1016/j.pmrj.2011.05.015
9. Brown J, Sivan M. Ultrasound-guided platelet-rich plasma injection for chronic patellar tendinopathy: a case report. PM R. 2010; 2(10): 969-72. doi: 10.1016/j.pmrj.2010.05.001
10. KonE,FilardoG,DelcoglianoM,PrestiML,RussoA,BondiA,Platelet-richplasma:newclinicalapplication:apilotstudy for treatment of jumper's knee. Injury. 2009; 40(6): 598-603. doi: 10.1016/j.injury.2008.11.026
11. Owens RF Jr, Ginnetti J, Conti SF, Latona C. Clinical and magnetic resonance imaging outcomes following platelet rich plasma injection for chronic midsubstance Achilles tendinopathy. Foot Ankle Int. 2011; 32(11): 1032-9. doi: 10.3113/FAI.2011.1032
12. Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011; 39(6): 1200-8. doi: 10.1177/0363546510397173
13. Scollon-Grieve KL, Malanga GA. Platelet-rich plasma injection for partial patellar tendon tear in a high school athlete: a case presentation. PM R. 2011; 3(4): 391-5. doi: 10.1016/j.pmrj.2010.11.008
14. Hechtman KS, Uribe JW, Botto-vanDemden A, Kiebzak GM. Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis. 2011; 34(2): 92. doi: 10.3928/01477447-20101221-05
15. Yuan T, Guo SC, Han P, Zhang CQ, Zeng BF. Applications of leukocyte- and platelet-rich plasma (L-PRP) in trauma surgery. Curr Pharm Biotechnol. 2012; 13(7): 1173-84. doi: 10.2174/138920112800624445
16. Zhang J, Wang JH. Platelet-richplasmareleasatepromotesdifferentiationoftendonstemcellsintoactivetenocytes.AmJSports Med. 2010; 38(12): 2477-86. doi: 10.1177/0363546510376750
17. Alsousou J, Ali A, Willett K, Harrison P. The role of platelet-rich plasma in tissue regeneration. 2013; 24(3): 173-82. doi: 10.3109/09537104.2012.684730
18. Anitua E, Andía I, Sanchez M, Azofra J, del Mar Zalduendo M, de la Fuente M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005; 23(2): 281-6. doi: 10.1016/j.orthres.2004.08.015
19. Chen L, Dong SW, Tao X, Liu JP, Tang KL, Xu JZ. Autologous platelet-rich clot releasate stimulates proliferation and inhibits differentiation of adult rat tendon stem cells towards nontenocyte lineages. J Int Med Res. 2012; 40(4): 1399-409. doi: 10.1177/147323001204000418
20. Taylor DW, Petrera M, Hendry M, Theodoropoulos JS. A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med. 2011; 21(4): 344-52. doi: 10.1097/JSM.0b013e31821d0f65
21. Parafioriti A, Armiraglio E, Del Bianco S, Tibalt E, Oliva F, Berardi AC. Single injection of platelet-rich plasma in a rat Achilles tendon tear model. Muscles Ligaments Tendons J. 2011; 1(2): 41-7.
22. Khan U, Occleston NL, Khaw PT, McGrouther DA. Differences in proliferative rate and collagen lattice contraction between endotenon and synovial fibroblasts. J Hand Surg Am. 1998; 23(2): 266-73. doi: 10.1016/S0363-5023(98)80125-1
23. Yoshikawa Y, Abrahamsson SO. Dose-related cellular effects of platelet-derived growth factor-BB differ in various types of rabbit tendons in vitro. Acta Orthop Scand. 2001; 72(3): 287-92. doi: 10.1080/00016470152846646
24. Rickert M, Jung M, Adiyaman M, Richter W, Simank HG. A growth and differentiation factor-5 (GDF-5)-coated suture stimulates tendon healing in an Achilles tendon model in rats. Growth Factors. 2001; 19(2): 115-26. doi: 10.3109/08977190109001080
25. Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med.2003;33(5):381-94.doi: 10.2165/00007256-200333050-00004
26. Kurtz CA, Loebig TG, Anderson DD, DeMeo PJ, Campbell PG. Insulin-like growth factor I accelerates functional recovery from Achilles tendon injury in a rat model. Am J Sports Med. 1999; 27(3): 363-9. doi: 10.1177/03635465990270031701
27. Chang J, Thunder R, Most D, Longaker MT, Lineaweaver WC. Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion. Plast Reconstr Surg. 2000; 105(1): 148-55. doi: 10.1097/00006534- 200001000-00025
28. Dhurat R, Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective. J Cutan Aesthet Surg. 2014; 7(4): 189-97. doi: 10.4103/0974-2077.150734
29. Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. 2012; 28(3): 429-39. doi: 10.1016/j.arthro.2011.10.018
30. JOrthoTrauma.2006; 20(8): S127.
31. Gould D. Visual Analogue Scale (VAS). Blackwell Science Ltd, J Clin Nurs. 2001; 10: 697-706. 68 http://www.blackwellpublishing.com/specialarticles/jcn_10_706.pdf (accessed on 28 February 2020)
32. Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996; 29(6): 602-8. doi: 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L. Erratum in: Am J Ind Med. 1996; 30(3): 372.
33. Macdermid J. Update: The Patient-rated Forearm Evaluation Questionnaire is now the Patient-rated Tennis Elbow Evaluation. J Hand Ther. 2005; 18(4): 407-10. doi: 10.1197/j.jht.2005.07.002
34. Nirschl RP. Elbow tendinosis/tennis elbow. Clin Sports Med.1992;11(4):851-70.
35. Evans RB. Managing the injured tendon: current concepts. J Hand Ther. 2012; 25(2): 173-89; quiz 190. doi: 10.1016/j.jht.2011.10.004
36. James R, Kesturu G, Balian G, Chhabra AB. Tendon: biology, biomechanics, repair, growth factors, and evolving treatment options. J Hand Surg Am. 2008; 33(1): 102-12. doi: 10.1016/j.jhsa.2007.09.007
37. Wang JH, Guo Q, Li B. Tendon biomechanics and mechanobiology—a mini review of basic concepts and recent advancements. J Hand Ther. 2012; 25(2): 133-40; quiz 141. doi: 10.1016/j.jht.2011.07.004
38. Assendelft WJ, Hay EM, Adshead R, Bouter LM. Corticosteroid injections for lateral epicondylitis: a systematic overview. Br J Gen Pract. 1996; 46(405): 209-16.
39. Riley GP, Curry V, DeGroot J, van ElB, Verzij lN, Hazleman BL, et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol. 2002; 21(2): 185-95. doi: 10.1016/s0945-053x(01)00196-2
40. Smidt N, van der Windt DA, Assendelft WJ, Devillé WL, Korthals-de Bos IB, Bouter LM. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. 2002; 359(9307): 657-62. doi: 10.1016/S0140-6736(02)07811-X
41. Wong SM, Hui AC, Tong PY, Poon DW, Yu E, Wong LK. Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2005; 143(11): 793-7. doi: 10.7326/0003-4819-143-11-200512060- 00007
42. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2008; 1(3-4): 165-74. doi: 10.1007/s12178-008-9032-5
43. Smidt N, Assendelft WJ, Arola H, Malmivaara A, Greens S, Buchbinder R, et al. Effectiveness of physiotherapy for lateral epicondylitis: a systematic review. Ann Med. 2003; 35(1): 51-62. doi: 10.1080/07853890310004138
44. Ferrari M, Zia S, Valbonesi M, Henriquet F, Venere G, Spagnolo S, et al. A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs. 1987; 10(1): 47-50.
45. Gautam VK, Verma S, Batra S, Bhatnagar N, Arora S. Platelet-rich plasma versus corticosteroid injection for recalcitrant lateral epicondylitis: clinical and ultrasonographic evaluation. J Orthop Surg (Hong Kong). 2015; 23(1): 1-5. doi: 10.1177/230949901502300101
46. Krogh TP, Fredberg U, Stengaard-Pedersen K, Christensen R, Jensen P, Ellingsen T. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. Am J Sports Med. 2013; 41(3): 625-35. doi: 10.1177/0363546512472975
47. Yadav R, Kothari SY, Borah D. Comparison of Local Injection of Platelet Rich Plasma and Corticosteroids in the Treatment of Lateral Epicondylitis of Humerus. J Clin Diagn Res. 2015; 9(7): RC05-7. doi: 10.7860/JCDR/2015/14087.6213
48. Nasser MET, El Yasaki AZ, Ezz El Mallah RM, Abdelazeem ASM. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline. A comparative study. Egypt Rheumatol Rehabil. 2017; 44: 1-10. doi: 10.4103/1110-161X.200838

Abstract   |   Reference